RAD-x adds Medizin Center Bonn to its fast growing diagnostic imaging platform - Gilde Healthcare

RAD-x adds Medizin Center Bonn to its fast growing diagnostic imaging platform

19 april 2021

Utrecht (the Netherlands) and Mannheim (Germany) – RAD-x, the leading European diagnostic imaging practice operator and portfolio company of Gilde Healthcare Private Equity, is adding Medizin Center Bonn (MCB) to its group. MCB provides cutting-edge premier nuclear medicine- and radiology services in the region of Bonn, NRW, Germany and is an acknowledged pioneer in PET/CT diagnostics.

MCB is the next medical imaging center in Germany to join the fast growing RAD-x Group in a short time. RAD-x Group differentiates by offering the highest medical quality, hands-on support for organisational and financial growth, e.g. for the procurement of heavy equipment, and the long-term development of regional practice clusters. RAD-x expects to welcome additional radiology centers to its platform in the course of this year.

About Gilde Healthcare
Gilde Healthcare is a specialized healthcare investor managing over €1.4 billion across two fund strategies: Private Equity and Venture & Growth.
Gilde Healthcare Private Equity participates in profitable European lower mid-market healthcare companies with a prime focus on the Benelux and DACH region. The Private Equity fund targets healthcare providers, suppliers of medical products and service providers in the healthcare market. Gilde Healthcare Venture & Growth invests in medtech, healthtech and therapeutics in Europe and North America.
For more information, visit the company’s website at www.gildehealthcare.com.

Gilde Healthcare appoints Dr. Christian Stark as Group CEO of its globally operating medical technology group

The medical technology group, which includes two manufacturers of surgical instruments in the Tuttlingen region, Koscher & Würtz and Christian Diener, has appointed Dr. Christian Stark as Chief Executive Officer (CEO) with effect from September...
3 september 2025

Gilde Healthcare kondigt succesvolle exit aan van portfoliobedrijf Novicare, een specialistische behandeldienst met medische en paramedische (tele)zorg, aan Gimv

Gilde Healthcare, de gespecialiseerde investeerder in de zorgsector, heeft een overeenkomst bereikt over de verkoop van haar Nederlandse portfoliobedrijf Novicare aan Gimv*. Novicare biedt uitbestede medische en paramedische (tele)zorg. Het bedrijf is gespecialiseerd in ouderenzorg...
28 augustus 2025

Gilde Healthcare company SynOx Therapeutics Completes Enrollment in Registrational Trial Significantly Ahead of Timeline

DUBLIN, IRELAND, OXFORD, UK, and PHILADELPHIA, PA -- August 5th, 2025 – SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing emactuzumab for Tenosynovial Giant Cell Tumours (TGCT), today announced completion of patient enrolment...
5 augustus 2025